Liposomes formulated with fMLP-modified cholesterol for enhancing drug concentration at inflammatory sites.

Qin, Yao; Li, Zi-wei; Yang, Yong; Yu, Chun-mei; Gu, Dan-dan; Deng, Hong; Zhang, Tao; Wang, Xin; Wang, Ai-ping; Luo, Wei-zao

Qin, Yao; Li, Zi-wei; Yang, Yong; Yu, Chun-mei; Gu, Dan-dan; Deng, Hong; Zhang, Tao; Wang, Xin; Wang, Ai-ping; Luo, Wei-zao.

Affiliation

Qin Y; Department of Medicinal Chemistry, Chongqing Institute of Traditional Chinese Medicine , Chongqing , China .

J Drug Target ; 22(2): 165-74, 2014 Feb.

Article in En | MEDLINE | ID: mdl-24392736

Subject(s)

Cholesterol/administration & dosage; Cholesterol/chemistry; Inflammation/drug therapy; Liposomes/administration & dosage; Liposomes/chemistry; N-Formylmethionine Leucyl-Phenylalanine/administration & dosage; N-Formylmethionine Leucyl-Phenylalanine/chemistry; Anti-Inflammatory Agents/administration & dosage; Anti-Inflammatory Agents/chemistry; Cell Differentiation/drug effects; Cell Line, Tumor; Chemistry, Pharmaceutical/methods; Drug Delivery Systems/methods; Humans; U937 Cells

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Main subject: Cholesterol / Inflammation / Liposomes / N-Formylmethionine Leucyl-Phenylalanine Type of study: Prognostic_studies Limits: Humans Language: En Journal: J Drug Target Journal subject: FARMACOLOGIA Year: 2014 Type: Article Affiliation country: China

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google